Literature DB >> 12641789

Epithelioid sarcoma: an immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma.

Lin Lin1, Marek Skacel, Jessica E Sigel, Wilma F Bergfeld, Elizabeth Montgomery, Cyril Fisher, John R Goldblum.   

Abstract

BACKGROUND: Epithelioid sarcoma (ES) is a rare, aggressive soft tissue tumor characterized by nodular aggregates of epithelioid and/or spindled cells that are immunoreactive to cytokeratins (CKs) and epithelial membrane antigen. ES that arises in the dermis may cause epidermal ulceration and can resemble, clinically, morphologically and immunohistochemically, cutaneous squamous cell carcinoma. CK 5/6 has recently been found to be an excellent marker of squamous cell carcinoma, including spindled variants, but it is not known if this marker can be utilized to distinguish superficial ES from cutaneous spindled squamous cell carcinoma (SSCC).
METHODS: Twenty-four cases of ES with typical histologic features and 10 cases of SSCC with ultrastructural evidence of epithelial differentiation were studied. Immunohistochemical analysis using an antibody to CK 5/6 was performed. The extent of immunoreactivity was evaluated in a semiquantitative manner using the following scale: 0, < 5% of cells staining; 1+, 6-25% of cells staining; 2+, 26-50% of cells staining; 3+, 51-75% of cells staining; 4+, > 75% of cells staining.
RESULTS: CK 5/6 was expressed in all 10 cases of SSCC, including one case with 3+ staining and six cases with 4+ staining. In contrast, CK 5/6 staining was found only in rare tumor cells (1+ staining) in one of 24 (4%) cases of ES.
CONCLUSIONS: CK 5/6 staining is useful in distinguishing superficial ES from cutaneous SSCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641789     DOI: 10.1034/j.1600-0560.2002.00040.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

Review 2.  Primary cutaneous SMARCB1-deficient carcinoma.

Authors:  Yiang Hui; Paolo Cotzia; Satshil Rana; Brie E Kezlarian; Oscar Lin; Travis J Hollmann; Snjezana Dogan
Journal:  J Cutan Pathol       Date:  2021-03-14       Impact factor: 1.458

3.  Proximal-type epithelioid sarcoma -- case report.

Authors:  Luciana Mendes dos Santos; Lisiane Nogueira; Christiane Yuri Matsuo; Carolina Talhari; Mônica Santos
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

Review 4.  Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma.

Authors:  Elisa Del Savio; Roberta Maestro
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.